ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Around the Dial: Broadcast & Media News Today – FYI Music News

Around the Dial: Broadcast & Media News TodayFYI Music NewsThe order also affected the music industry: proposed copyright changes are now either nullified, or in a best-case scenario, in suspended animation until powers-that-be figure out the next … Continue reading

2017-01-24 Michael Zand NEWS

AGTC and Bionic Sight Partner to Restore Vision Using Optogenetic Therapy – Genetic Engineering & Biotechnology News (press release)

Continue reading

2017-01-24 Michael Zand NEWS

Armed with $16M, Cue Biopharma Aims for Selective Immunotherapy – Xconomy

AGTC and Bionic Sight Partner to Restore Vision Using Optogenetic Therapy
Genetic Engineering & Biotechnology News (press release)
Applied Genetic Technologies (AGTC) and Bionic Sight are teaming up to develop a new form of optogenetic therapy that can restore vision in patients who have visual deficiencies or are blind as a result of retinal disease. The technology will combine …
AGTC and Bionic Sight Announce Strategic Collaboration to Develop an Optogenetic Therapy and Device for Visual …Yahoo Finance

all 3 news articles »

Continue reading

2017-01-24 Michael Zand NEWS

AGTC and Bionic Sight Announce Strategic Collaboration to Develop an Optogenetic Therapy and Device for Visual … – Yahoo Finance


Xconomy

Armed with $16M, Cue Biopharma Aims for Selective Immunotherapy
Xconomy
Cue is now unveiling its immunotherapy approach, along with $16.4 million in new capital, led by MDB Capital Group. The investment follows $10 million in seed funding the company raised after it was founded in 2015. The technology underlying Cue’s …
Cue Biopharma Debuts With $26 Million in Invested Capital to Develop Next-Generation Biologics to Selectively …Yahoo Finance

all 3 news articles »

Continue reading

2017-01-24 Michael Zand NEWS

AGTC and Bionic Sight Announce Strategic Collaboration to Develop an Optogenetic Therapy and Device for Visual … – Yahoo Finance

AGTC and Bionic Sight Announce Strategic Collaboration to Develop an Optogenetic Therapy and Device for Visual …
Yahoo Finance
“AGTC is excited to combine our expertise in gene therapy and ophthalmology with Bionic Sight’s transformative device that incorporates the retina’s neural code to improve the lives of patients with retinal disorders,” said Sue Washer, President and …

and more »

Continue reading

2017-01-24 Michael Zand NEWS

Pioneering Stem Cell Technique Promise Muscle Regeneration Without Cancer Risk – TrendinTech

AGTC and Bionic Sight Announce Strategic Collaboration to Develop an Optogenetic Therapy and Device for Visual …
Yahoo Finance
“AGTC is excited to combine our expertise in gene therapy and ophthalmology with Bionic Sight’s transformative device that incorporates the retina’s neural code to improve the lives of patients with retinal disorders,” said Sue Washer, President and …

and more »

Continue reading

2017-01-24 Michael Zand NEWS

Following Trump won’t cheer up industry – Nikkei Asian Review


TrendinTech

Pioneering Stem Cell Technique Promise Muscle Regeneration Without Cancer Risk
TrendinTech
A new revolutionary stem cell technique is being used to treat those suffering from damaged muscles without the cancer risk that was previously present. This was the first time that researchers had successfully implanted synthetic stem cardiac cells …
UW spinoff wins grant to advance stem cell researchWisconsin State Farmer
Stem Cell Market to Project Decent Growth Globally by 2024 | Hexa ResearchMedgadget (blog)
Stem Cell Research: Scientists Demonstrate How To Create Stem Cells From Skin CellsCounsel & Heal
Satellite PR News (press release) –Military Technologies
all 12 news articles »
Continue reading

2017-01-24 Michael Zand NEWS

Stempeutics receives European Process Patent for stem cell drug Stempeucel – Hindu Business Line


Nikkei Asian Review

Following Trump won’t cheer up industry
Nikkei Asian Review
Noriyuki Yanagawa, a University of Tokyo professor, predicts that U.S. industries will find themselves in a state of suspended animation during the next four years. Trump will stick to his “America first” trade policy and come down hard on importers he …

and more »

Continue reading

2017-01-24 Michael Zand NEWS
  • 1
  • …
  • 2,183
  • 2,184
  • 2,185
  • 2,186
  • 2,187
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Stempeutics receives European Process Patent for stem cell drug Stempeucel
Hindu Business Line
Stempeutics Research, an advanced clinical stage biotech company, today announced that the European Patent Office (EPO) has granted a process patent for its novel stem cell-based drug Stempeucel. “We have received European Process Patent for our …

and more »